Clinical Trials Browser

Carcinoma, Medullary

NCT07383246 2026-02-03

CAST-MTC

Phase 3 Recruiting

150 enrolled

Carcinoma, Medullary

NCT03892993 2026-01-09

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

Phase NA Recruiting

120 enrolled

Carcinoma, Medullary

NCT07259304 2025-12-02

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Recruiting

250 enrolled

CNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Bone Neoplasms, Brain Neoplasms, Uterine Cervical Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Ovarian Neoplasms, Testicular Neoplasms, Colorectal Neoplasms, Central Nervous System Neoplasms, Carcinoma, Medullary

NCT02856347 2025-11-18

CMTpostopFDOPA

Phase NA Completed

24 enrolled

Carcinoma, Medullary

NCT02293954 2025-11-14

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Phase NA Active not recruiting

20 enrolled 8 charts

BreastGastrointestinalThoracic

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Carcinoma, Medullary

NCT04759911 2025-11-13

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Phase 2 Active not recruiting

30 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT07142005 2025-10-22

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

Not yet recruiting

40 enrolled

Carcinoma, Medullary

NCT06814496 2025-10-09

RABBIT

Phase 1/2 Recruiting

30 enrolled

CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

NCT07138716 2025-08-24

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Phase NA Recruiting

30 enrolled

Carcinoma, Medullary

NCT07118176 2025-08-12

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Phase 1 Recruiting

30 enrolled

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETSarcomaThoracic

Adrenal Gland Neoplasms, Anus Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary, Cholangiocarcinoma, Neuroendocrine Tumors, Solitary Fibrous Tumors

NCT04877613 2025-07-03

GFRα4 CAR T Cells in MTC Patients

Phase 1 Active not recruiting

18 enrolled

Carcinoma, Medullary

NCT07048964 2025-07-03

A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations

Not yet recruiting

40 enrolled

Carcinoma, Medullary

NCT05534594 2025-06-24

MIMETIC

Phase NA Completed

8 enrolled

EndocrineHead & Neck

Thyroid cancer, medullary, Thyroid Neoplasms, Carcinoma, Medullary

NCT03583528 2025-06-13

DOTATOC PET/CT for Imaging NET Patients

Active not recruiting

800 enrolled

CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT04522570 2025-04-30

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Phase NA Active not recruiting

84 enrolled

Head & Neck

Lymphatic Metastasis, Thyroid Neoplasms, Carcinoma, Medullary

Clinical Trials

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

CAST-MTC

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

CMTpostopFDOPA

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

RABBIT

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

GFRα4 CAR T Cells in MTC Patients

A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations

MIMETIC

DOTATOC PET/CT for Imaging NET Patients

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma